S 2051
116th Congress
Senate
Health
Administrative law and regulatory procedures
Civil actions and liability
Congressional oversight
Consumer affairs
Health care costs and insurance
Health information and medical records
Insurance industry and regulation
Medicare
Prescription drugs
Retail and wholesale trades
Strengthening Average Sales Price Reporting Act of 2019
Introduced: June 28, 2019
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 28, 2019
Read twice and referred to the Committee on Finance.
Jun 28, 2019
Introduced in Senate
Plain-English summary
Strengthening Average Sales Price Reporting Act of 2019
This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1
Cosponsors
1